Forum für Wissenschaft, Industrie und Wirtschaft

Hauptsponsoren:     3M 
Datenbankrecherche:

 

Siemens presents new product lines for angiography

26.11.2012
The Artis Q and Artis Q.zen introduce groundbreaking new X-ray tube and detector technology

Siemens Healthcare has developed a revolutionary new X-ray tube and detector technology for its Artis Q and Artis Q.zen angiography systems to improve minimally invasive therapy of diseases such as coronary artery disease, stroke and cancer.



In both the Artis Q and Artis Q.zen series, the new X-ray tube can help to identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this innovative X-ray source with a new detector technology that supports interventional imaging in ultra-low-dose ranges.

This protects patients, doctors and medical staff, especially during longer interventions. With these new developments, presented for the first time at the 98th Congress of the Radiological Society of North America (RSNA), Siemens Healthcare has once again demonstrated its innovative strength and market competitiveness as part of its Agenda 2013 global Sector initiative.

Two hardware components are crucial for angiographic image quality: the X-ray tube and the detector. The X-rays emitted by the tube pass through the patient and hit the detector, which converts them to image signals.

The second generation of Siemens' flat emitter technology is key to the advances made in the X-ray tube for the Artis Q and Artis Q.zen product lines. Instead of the coiled filaments used in conventional X-ray tubes, flat emitter technology is used exclusively in the new tube to emit electrons. Flat emitters enable smaller quadratic focal spots that lead to improved visibility of small vessels by up to 70 percent. Both physicians and patients benefit from a high level of detail in imaging-supported interventional therapy. Neurologists can more precisely measure the blood circulation in specific areas of the brain, for example; while stenoses in the heart's smallest blood vessels can be spotted in coronary angiography.

Examinations using ultra-low dose radiation

The Artis Q.zen series combines the X-ray tube with a detector technology that allows detection at ultra-low radiation levels. Artis Q.zen imaging can use doses as low as half the usual levels normally applied in angiography. This improvement is the result of several innovations, including a fundamental change in detector technology. Until now, almost all detectors have been based on amorphous silicon. The new crystalline silicon structure of the Artis Q.zen detector is more homogenous, allowing for more effective amplification of the signal, greatly reducing the electronic noise even at ultra-low doses.

The Artis Q.zen was developed to support better imaging quality at ultra-low-dose ranges, reducing the radiation exposure of patients, physicians, and medical staff. This is especially important in dose-sensitive application fields such as pediatric cardiology and radiology, or electrophysiology, which is being used on more and more patients as rates of cardiac arrhythmia increase in an aging population.

Innovative applications for interventional imaging

In addition to the hardware innovations are several software applications that improve interventional imaging. In coronary artery disease treatment, the applications allow precise correlation of angiography images with ultrasound images taken by a probe inside the coronary arteries. Stents are imaged in real-time during therapy, with motion stabilization created by simultaneous correction for the heartbeat.

Other new 3D applications can image the smallest structures inside the head. Their high spatial resolution is crucial for imaging intracranial stents or other miniscule structures, such as the cochlea in the inner ear. Moving organs such as the lungs can be imaged in 3D in less than 3 seconds, reducing the number of motion artifacts and the amount of contrast agent required. Through visualization and measurement of blood volumes in the liver or other organs, Siemens' functional 3D imaging provides a basis for planning therapies such as chemo-embolization of hepatic tumors.

Launched in November 2011 by the Siemens Healthcare Sector, "Agenda 2013" is a two-year global initiative to further strengthen the Healthcare Sector's innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2012 (to September 30), the Sector posted revenue of 13.6 billion euros and profit of 1.8 billion euros. For further information please visit: http://www.siemens.com/healthcare

The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

Reference Number: HIM201211007e

Contact
Mr. Ulrich Künzel
Healthcare Sector
Siemens AG
Henkestr. 127
91052 Erlangen
Germany
Tel: +49 (9131) 84-3473
ulrich.kuenzel@siemens.com

Ulrich Künzel | Siemens Healthcare
Further information:
http://www.siemens.com/healthcare

More articles from Medical Engineering:

nachricht New investigation of endovenous laser ablation of varicose veins
11.05.2016 | Kazan Federal University

nachricht A laser for your eyes
18.04.2016 | Lomonosov Moscow State University

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Ein negatives Enzym liefert positive Resultate

In den letzten zwanzig Jahren hat die Chemie viele wichtige Instrumente und Verfahren für die Biologie hervorgebracht. Heute können wir Proteine herstellen, die in der Natur bisher nicht vorkommen. Es lassen sich Bilder von Ausschnitten lebender Zellen aufnehmen und sogar einzelne Zellen in lebendigen Tieren beobachten. Diese Woche haben zwei Forschungsgruppen der Universitäten Basel und Genf, die beide dem Nationalen Forschungsschwerpunkt Molecular Systems Engineering angehören, im Forschungsmagazin «ACS Central Science» präsentiert, wie man ein nicht-natürliches Protein designt, das völlig neue Fähigkeiten aufweist.

Proteine sind die Arbeitspferde jeder Zelle. Sie bestehen aus Aminosäurebausteinen, die als Kette verbunden sind, welche sich zu funktionalen Maschinen...

Im Focus: Atomic precision: technologies for the next-but-one generation of microchips

In the Beyond EUV project, the Fraunhofer Institutes for Laser Technology ILT in Aachen and for Applied Optics and Precision Engineering IOF in Jena are developing key technologies for the manufacture of a new generation of microchips using EUV radiation at a wavelength of 6.7 nm. The resulting structures are barely thicker than single atoms, and they make it possible to produce extremely integrated circuits for such items as wearables or mind-controlled prosthetic limbs.

In 1965 Gordon Moore formulated the law that came to be named after him, which states that the complexity of integrated circuits doubles every one to two...

Im Focus: FS POSEIDON startet zur 500. Expedition

Das am GEOMAR Helmholtz-Zentrum für Ozeanforschung Kiel beheimatete Forschungsschiff POSEIDON startet diese Woche zu seiner 500. Expedition. Während der Jubiläumsfahrt untersuchen und kartieren Meeresgeologen des MARUM – Zentrum für Marine Umweltwissenschaften der Universität Bremen den Kontinentalhang vor der südfranzösischen Hafenstadt Nizza. Ziel der Arbeiten ist es, die Gefahr von Hangrutschungen und letztendlich auch Tsunamis besser abschätzen zu können.

Am kommenden Mittwoch heißt es wieder einmal „Leinen los“ für die POSEIDON. Von Catania auf Sizilien aus nimmt das 60 Meter lange Forschungsschiff Kurs auf die...

Im Focus: Spinströme: Riesengroß und ultraschnell

Mit einer neuen Methode der TU Wien lassen sich extrem starke Spinströme herstellen. Sie sind wichtig für die Spintronik, die unsere herkömmliche Elektronik ablösen könnte.

In unseren Computerchips wird Information in Form von elektrischer Ladung übertragen. Elektronen oder andere Ladungsträger werden von einem Ort zum anderen...

Im Focus: Researchers demonstrate size quantization of Dirac fermions in graphene

Characterization of high-quality material reveals important details relevant to next generation nanoelectronic devices

Quantum mechanics is the field of physics governing the behavior of things on atomic scales, where things work very differently from our everyday world.

Alle Focus-News des Innovations-reports >>>

Anzeige

Anzeige

IHR
JOB & KARRIERE
SERVICE
im innovations-report
in Kooperation mit academics
Veranstaltungen

Innovationen für Laserexperten und Anwender - Universität Stuttgart bei Stuttgarter Lasertagen 2016

24.05.2016 | Veranstaltungen

Verlorene Körperfunktion wiederherstellen

24.05.2016 | Veranstaltungen

Autopilotensysteme beim Hubschrauber und deren Weiterentwicklung hin zum unbemannten Flug

24.05.2016 | Veranstaltungen

 
B2B-VideoLinks
Weitere VideoLinks >>>
Aktuelle Beiträge

Schmelzende Kristalle und modifizierte Proteine

24.05.2016 | Biowissenschaften Chemie

Ein negatives Enzym liefert positive Resultate

24.05.2016 | Biowissenschaften Chemie

Medikamentöse Destabilisierung eines Proteinkomplexes lässt Lebertumorzellen absterben

24.05.2016 | Biowissenschaften Chemie